Caplin Steriles receives EIR from US FDA
The inspection classification was determined by the agency as Voluntary Action Indicated
The inspection classification was determined by the agency as Voluntary Action Indicated
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
This approval has come from the company's finished dosage form manufacturing facility
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Subscribe To Our Newsletter & Stay Updated